Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-21

Clinical Trial Update: Alveolar Ridge Augmentation With Curcumin Combined With Xenograft [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring alveolar ridge augmentation using curcumin combined with xenograft for horizontal alveolar bone loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)
  • Xenograft (Xenograft bone graft material)

Snippet

Sponsor: Ain Shams University | Conditions: Horizontal Alveolar Bone Loss | Phase 4 | Status: UNKNOWN